PRKCE and acute myeloid leukemia: PKCε was associated with poor OS and DFS (mRNA) and CR-induction (protein), suggesting that PKCε could be an indicator of poor treatment response; findings which are supported by observations in solid cancer (4) and a study describing a risk prediction model which incorporated multiple AML molecular datasets (RNAseq, methylation, GEP and SNP) (55).